Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults

Condition:   Typhoid Fever Interventions:   Biological: TYP04A Low Dose without adjuvant investigational vaccine;   Biological: TYP04B Full Dose without adjuvant investigational vaccine;   Biological: TYP03A Low Dose adjuvanted investigational vaccine;   Biological: TYP03B Full Dose adjuvanted investigational vaccine;   Biological: Sa nofi Pasteur's Typhoid Vi polysaccharide vaccine;   Biological: GSK's Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine Sponsors:   GlaxoSmithKline;   Biological E. Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials